Ion Therapy Patient Registry

Last updated: May 7, 2025
Sponsor: EBG MedAustron GmbH
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Protons and Carbon Ions

Clinical Study ID

NCT03049072
REGI-MA-002015
  • All Genders

Study Summary

The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with tumor disease treated with ion beam therapy at MedAustron

  • Signed informed consent form

Exclusion

Exclusion Criteria:

  • Comorbidities endangering treatment delivery or study compliance

Study Design

Total Participants: 2100
Treatment Group(s): 1
Primary Treatment: Protons and Carbon Ions
Phase:
Study Start date:
December 01, 2016
Estimated Completion Date:
December 31, 2036

Study Description

During and up to 10 years after radiation therapy data regarding tumor control and treatment response as well as acute and late toxicities will be collected at regular time intervals. Additionally quality of life and sociodemographic status will be assessed in all study patients and neurocognitive assessment will be performed in patients undergoing ion radiation of the brain.

Connect with a study center

  • EBG MedAustron GmbH

    Wiener Neustadt, Niederösterreich 2700
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.